Skip to main content
Contact Us
Subscribe
E-Edition
95°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Ibogaine
Recent news which mentions Ibogaine
At 77, Cannabis Champion Dana Beal Fights Idaho Laws To Push Legalization In Hostile Territory
March 26, 2024
Tickers
NEWS
Tags
Idaho cannabis
Government
News
From
Benzinga
Cannabis Crusader Dana Beal's Incarceration: A Blow To Legalization Advocacy And Psychedelic Policy Reform
January 25, 2024
Tags
Dana Beal
Ibogaine
NYC Cannabis Parade
From
Benzinga
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
January 07, 2024
Tickers
AMA
ATAI
CMND
CMPS
Tags
IXHL
News
CMPS
From
Benzinga
This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health
September 25, 2023
Tags
Anna Trevorrow
Benzinga
Market News
From
Benzinga
Psychedelics To Treat Addiction? How Substances Like Ibogaine Are Changing The Game
August 26, 2023
Tags
opioid addiction
Benzinga
contributors
From
Benzinga
African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
May 17, 2023
Tickers
FLHLF
Tags
FLHLF
Benzinga
Iboga Plant
From
Benzinga
EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects
April 27, 2023
Tags
Markets
Exclusives
Management
From
Benzinga
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
January 24, 2023
Tickers
PSYCF
PSYGF
TRUFF
Tags
Ibogaine
Psychedelics
Market News
From
Benzinga
Ibogaine To Treat Addiction: 5 Reasons Why It's Safer To Do It In Hospital Settings
November 21, 2022
Tags
Psychedelic
General
Dr/ Bruno Rasmussen Chaves
From
Benzinga
Science Feature: Next-Generation Psychedelics
July 31, 2022
Tickers
DMT
Tags
Benzinga
contributors
Cannabis
From
Benzinga
MindMed Reports Promising Results For Non-Hallucinogenic Ibogaine Congener Substance
May 19, 2022
Tickers
MNMD
Tags
Markets
MindMed
News
From
Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
Tickers
ATAI
AWKNF
CYBN
ENVB
Tags
News
ATAI
MNMD
From
Benzinga
What Is Iboga And How Does It Compare To Cannabis, Exactly?
April 02, 2022
Tags
contributors
Benzinga
Market News
From
Benzinga
5 Psychedelics For Mental Health
February 01, 2022
Tags
Market News
Cannabis
contributors
From
Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
January 19, 2022
Tickers
DMT
MDMA
Tags
psilocybin
Defiance Altered Experience ETF (PSY)
Compass Pathways
From
Stock Gumshoe
MindMed Successfully Completes Phase 1 Trial Of 18-MC
January 19, 2022
Tickers
MNMD
Tags
MNMD
clinical trial
psychedelics
From
Benzinga
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
Tickers
ATAI
NVMDF
Tags
Delix Therapeutics
Cannabis
Market News
From
Benzinga
Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders
December 02, 2021
Tickers
MAPS
NVMDF
Tags
Government
Bienstar Wellness Corp
General
From
Benzinga
New Study Links Psychedelic Use With 55 Percent Decrease In Daily Opioid Use
November 17, 2021
Tags
Ibogaine
Drug Policy
dosed film
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.